Rebecca Vanderpool, PhD
LightNews LightNews
banner
rrvdpool.bsky.social
Rebecca Vanderpool, PhD
@rrvdpool.bsky.social
260 followers 210 following 61 posts
A biomedical engineer researching right ventricular function and pulmonary vascular disease. #PAH #PulmonaryCirculation Opinions are mine. #Medsky
Posts Replies Media Videos
rrvdpool.bsky.social
Excited for #AHA25 to start. The ever popular 3CPR Speed Mentoring session is happening this afternoon. Later there is both an early career networking event and the 3CPR & #ReSS welcome reception. A jammed packed afternoon.
November 7, 2025 at 7:17 PM
Reposted by Rebecca Vanderpool, PhD
ats-pc.bsky.social
Here are some helpful PC-links with our latest activity:
🛜🔗
What's New: site.thoracic.org/assemblies/p....
PC Webinars: site.thoracic.org/assemblies/p...
Practical PH Podcasts: site.thoracic.org/assemblies/p...
October 22, 2025 at 1:07 AM
Reposted by Rebecca Vanderpool, PhD
nejm.org
Among adults with pulmonary arterial hypertension who had received the diagnosis less than 1 year earlier, the addition of sotatercept to background therapy resulted in a lower risk of clinical worsening than placebo. Full HYPERION phase 3 trial results and Research Summary: nej.md/4mzuaY1
The New England Journal of Medicine Sotatercept for Pulmonary Arterial Hypertension within the First Year A Research Summary based on McLaughlin VV et al. | 10.1056/NEJMoa2508170 | Published on September 30, 2025 Visual representations of the patients in the trial and the treatments they were assigned. Read the full Research Summary at NEJM.org.
October 3, 2025 at 4:04 PM
Reposted by Rebecca Vanderpool, PhD
ats-pc.bsky.social
🚨 New trial alert: HYPERION🚨
nejm.org NEJM.org @nejm.org · Oct 3
Among adults with pulmonary arterial hypertension who had received the diagnosis less than 1 year earlier, the addition of sotatercept to background therapy resulted in a lower risk of clinical worsening than placebo. Full HYPERION phase 3 trial results and Research Summary: nej.md/4mzuaY1
The New England Journal of Medicine Sotatercept for Pulmonary Arterial Hypertension within the First Year A Research Summary based on McLaughlin VV et al. | 10.1056/NEJMoa2508170 | Published on September 30, 2025 Visual representations of the patients in the trial and the treatments they were assigned. Read the full Research Summary at NEJM.org.
October 10, 2025 at 3:47 AM
Reposted by Rebecca Vanderpool, PhD
ats-assemblies.bsky.social
Troy Stevens, PhD presenting the Terry Wagner Memorial Lecture: Impact of Age on Endothelial Heterogeneity in the Pulmonary Vasculature
@ats-pc.bsky.social #groverconference2025
September 4, 2025 at 2:26 PM
Reposted by Rebecca Vanderpool, PhD
profrausch.bsky.social
🚨 We have 2-3 post-doc openings and an opening for a lab manager, all in soft material/tissue mechanics. 🚨

Check out www.manuelrausch.com and submit an application here: lnkd.in/e7W27XwZ. Please share with interested parties and your network. Many thanks ❤️!
Soft Tissue Biomechanics Laboratory
www.manuelrausch.com
July 12, 2025 at 9:01 PM
Reposted by Rebecca Vanderpool, PhD
ats-pc.bsky.social
Happy Monday! Let's start the week right with an early career highlight 🥁 Introducing Dr. Forbes:
June 30, 2025 at 2:53 PM
Reposted by Rebecca Vanderpool, PhD
atsblueeditor.bsky.social
The Blue Journal thanks Alexander M. K. Rothman, BMBCh, MRCP, PhD, for his contribution to the June issue

Positioning Imatinib for Pulmonary Arterial Hypertension: A Dose-Finding Phase 2 Study

@atscommunity.bsky.social‬ #PAH

🔓Open Access

www.atsjournals.org/doi/full/10....
June 17, 2025 at 6:01 PM
Reposted by Rebecca Vanderpool, PhD
pvrinstitute.bsky.social
📢 Get ready to submit your abstract to PVRI 2026 Dublin — registrations & the abstract portal will open on 1 July! Stay tuned for full details on how to register and submit your abstract! pvrinstitute.org/pvri2026
#PVRI2026 #PulmonaryHypertension #GlobalScience #Congress
June 11, 2025 at 11:31 AM
Reposted by Rebecca Vanderpool, PhD
ats-pc.bsky.social
Hot off the press 🔥: Check out this guideline summary on interventional strategies for children with progressive pulmonary hypertension in the June issue of Annals ATS. www.atsjournals.org/doi/full/10....
Summary for Clinicians: Clinical Practice Guideline on Interventional Strategies for Children with Progressive Pulmonary Hypertension Despite Optimal Therapy | Annals of the American Thoracic Society
Artificial Intelligence Disclaimer: No artificial intelligence tools were used in writing this manuscript
www.atsjournals.org
June 11, 2025 at 6:35 PM
Reposted by Rebecca Vanderpool, PhD
atscommunity.bsky.social
⏰ Submit your proposals for ATS 2026 in Orlando!

📅 Call for input is open now through June 25. Learn more in ATS Conference News: www.atsconferencenews.org/ats-2026-int...
ATS 2026 International Conference Call for Input Open Now - ATSConferenceNews.org
The ATS 2026 International Conference will take place May 15-20, 2026, in Orlando, but the call for input for next year’s conference has already opened! Submit your proposals for numerous Internationa...
www.atsconferencenews.org
June 2, 2025 at 4:04 PM
Reposted by Rebecca Vanderpool, PhD
ats-pc.bsky.social
Missing all the networking at ATS 2025? Here is a PC Assembly early career highlight! Meet Dr. Shen:
June 2, 2025 at 9:41 PM
Reposted by Rebecca Vanderpool, PhD
maryamsanjani.bsky.social
Please join our latest discussions: tle: “3D Imaging Reveals Complex Microvascular Remodeling in the Right Ventricle in
Pulmonary Hypertension”
Date/Time: Tues, June. 3, 2025, 12 p.m. eastern
Registration Link:
thoracic.zoom.us/meeting/regi...
Presenter: Edda Spiekerkoetter, MD
Welcome! You are invited to join a meeting: 3D Imaging Reveals Complex Microvascular Remodeling in the Right Ventricle in Pulmonary Hypertension. After registering, you will receive a confirmation ema...
Dr. Edda Spiekerkoetter, MD from Stanford will present the article titled "3D Imaging Reveals Complex Microvascular Remodeling in the Right Ventricle in Pulmonary Hypertension” and discuss the topic b...
thoracic.zoom.us
April 18, 2025 at 11:42 AM
Reposted by Rebecca Vanderpool, PhD
maryamsanjani.bsky.social
Happening this Tuesday!
May 27, 2025 at 12:52 PM
Reposted by Rebecca Vanderpool, PhD
ats-assemblies.bsky.social
🩺 Join us for the @ats-pc.bsky.social journal club next week!
📅 Tue, June 3, 2025, 12pm ET
🎤 Presenter: Dr. Edda Spiekerkoetter, MD
Register Now! thoracic.zoom.us/meeting/regi...
May 27, 2025 at 1:29 PM
rrvdpool.bsky.social
Excellent job covering #ATS2025. Thanks for your hard work!
ats-pc.bsky.social ATS PC Assembly @ats-pc.bsky.social · May 21
And with that, the PC Web Committee (Chair: Dr. Khushboo Goel / Co-Chair: Dr. Kathryn del Valle / Member: Dr. Katherine Cox-Flaherty) aka the PH-aparazzi is signing off #ATS2025! 📸 📹🤳We had a blast sharing all the PC action with you all. 👋👋👋
@atscommunity.bsky.social @atsearlycareer.bsky.social
May 22, 2025 at 5:25 AM
Reposted by Rebecca Vanderpool, PhD
ats-pc.bsky.social
The PHun doesn’t stop there! Head over to the Poster Discussion on Late-Breaking Abstracts in 3009/3011 or Mini Symposium on Novel Models of Metabolism and Vascular Remodeling in 2009/2011. 👟👟
May 21, 2025 at 5:59 PM
Reposted by Rebecca Vanderpool, PhD
ats-pc.bsky.social
PC has saved some of the best sessions for last at #ATS2025
⏰Wednesday May 21 starting at 8:15 AM PST - all in Moscone West so you don't have to miss out on anything!🙌
May 21, 2025 at 2:13 AM
Reposted by Rebecca Vanderpool, PhD
brownpvd.bsky.social
This afternoon’s #ATS2025 session has been wonderful! Our own #CoreyVentetuolo spoke about lessons we’ve learned about EC plasticity from our cell biopsy method. @brownmedicine.bsky.social @ats-pc.bsky.social
May 19, 2025 at 10:53 PM
Reposted by Rebecca Vanderpool, PhD
ats-pc.bsky.social
Let’s update “low risk” in #PAH! Awesome presentation from
@SandeepSahayMD
& team: “A Refined Definition of Low Risk in Patients with PAH: Incorporating Mortality and Morbidity”
May 19, 2025 at 5:19 PM
Reposted by Rebecca Vanderpool, PhD
ats-pc.bsky.social
Big things happening this morning in B26 - Oracle Park 👁️👁️ come check it out!
May 19, 2025 at 5:05 PM
Reposted by Rebecca Vanderpool, PhD
ats-pc.bsky.social
Kicking things off with very encouraging data looking at survival with PAH using analyses from STELLAR and SOTERIA trials!
May 19, 2025 at 9:47 PM
Reposted by Rebecca Vanderpool, PhD
nickbruin.bsky.social
Don’t forget this one!! Navigating Mid Career challenges from PAH luminaries.
May 19, 2025 at 6:03 PM
Reposted by Rebecca Vanderpool, PhD
ats-pc.bsky.social
Good Morning and welcome to another awesome day at #ATS2025! Today is jam-packed with 🔥#PVD #PH #RV #PulmCirc sessions, so put those 👟on & get excited for all these great presentations 🎉 And don’t miss our
@ats-pc.bsky.social
meeting TODAY at 5p! Today’s sessions ⬇️
May 19, 2025 at 5:09 PM
Reposted by Rebecca Vanderpool, PhD
ats-pc.bsky.social
Looking to the PH-uture 👀: Mapping the Chemical Shift of 20Xenon in the Red Blood Cells as a Biomarker for PH. #DrBastianDriehuys
May 19, 2025 at 5:27 PM